Pharmacogenomics as a Service - NW GMSA PROGRESS PROGRAMME
The "Pharmacogenetics as a Service" component of the PROGRESS Programme aims to develop a digital solution which allows the persistence and messaging of pharmacogenetic data. This will be performed in the context of an initial pilot as part of the wider PROGRESS Programme, but any solution should have the potential to scale across the NHS.
Buyer
Manchester University NHS Foundation Trust
Value
£268,488
Published
24 Dec 2024
Closes
23 Oct 2024
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Selective
Category
Goods
Contract starts
17 Dec 2024
Contract ends
31 Mar 2026
CPV classifications
48000000
Software package and information systems
Lots
Lot default Pharmacogenomics as a Service - NW GMSA PROGRESS PROGRAMME
£268,488
The "Pharmacogenetics as a Service" component of the PROGRESS Programme aims to develop a digital solution which allows the persistence and messaging of pharmacogenetic data. This will be performed in the context of an initial pilot as part of the wider PROGRESS Programme, but any solution should have the potential to scale across the NHS.
Documents
Unlock document linkAwarded contract notice on Contracts Finder
24 Dec 2024
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.